Key facts
- Notable investors include Tech Incubator Program for Startup, Genaxis (Korea), HB Investment, Pathfinder H.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MediQstar
- ·The full record, as it builds
Funding rounds
No funding rounds for MediQstar are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MediQstar
Developer of a medical technology designed for tuberculosis diagnosis. The company uses generative AI technology to establish a new process for existing complex and difficult clinical trials, providing clients with biosimulation to reduce period and cost significantly.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2023
- Employees
- 15
- Website
- mediqstar.com/
- Ownership
- Privately Held (backing)
MediQstar doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediQstar shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediQstar in its N-PORT filings yet. We sweep new filings monthly.